Lucie MANACHE-ALBERICI

Lucie Manache-Alberici is the Analytical Development Director at TreeFrog Therapeutics (Bordeaux, France) where she is responsible for the analytical development of methods tailored to both the iPSCs starting materials and derived microtissues. Lucie’s team is also heavily involved in the continuous development of TreeFrog's C-Stem™ technology, providing pragmatic analytical tools to support the innovation from the manufacturing platform. Lucie has 18+ years of experience in the Biotech and Pharma industry. Before joining TreeFrog, she worked at Sanofi, and Merck KGaA where she was involved in multiple CMC projects, including product development, characterization, formulation and analytical development. Lucie holds a Pharm.D. and a MSc. in Process Engineering from ENSIC (Nancy, France). TreeFrog Therapeutics is a French Biotech company with the purpose of making efficient and affordable cell therapies available to all patients using their proprietary technology platform, C-Stem™ which overcomes some of the major challenges of delivering quality cell therapies at scale, efficiently.